DRUG HCC-P3-11-01: Phase 3 Prospective, Randomized, Blinded and Controlled Investigation of Hepasphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer

Project: Research project

StatusActive
Effective start/end date10/30/1210/30/22

Funding

  • Merit Medical Systems, Inc. (DRUG HCC-P3-11-01)